Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TKNO is expected to report earnings to rise 18.25% to -9 cents per share on March 17
Q4'25
Est.
$-0.09
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 120.95K shares outstanding, the current market capitalization sits at 237.40M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TKNO showed earnings on November 06, 2025. You can read more about the earnings report here.